BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C
12 results:

  • 1. Prospective Characterization of Circulating Tumor Cell Kinetics in Patients With Oligometastatic Disease Receiving Definitive Intent Radiation Therapy.
    Sud S; Poellmann MJ; Hall J; Tan X; Bu J; Myung JH; Wang AZ; Hong S; Casey DL
    JCO Precis Oncol; 2023 Sep; 7():e2300303. PubMed ID: 38096474
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Alternative splicing events as peripheral biomarkers for motor learning deficit caused by adverse prenatal environments.
    Dutta DJ; Sasaki J; Bansal A; Sugai K; Yamashita S; Li G; Lazarski C; Wang L; Sasaki T; Yamashita C; Carryl H; Suzuki R; Odawara M; Imamura Kawasawa Y; Rakic P; Torii M; Hashimoto-Torii K
    Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2304074120. PubMed ID: 38051767
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Comparison of 2 Disease Burden Assessment Methods (3D Volume Versus the Number of Lesions) for Prognostication of Survival in Metastatic Melanoma: Implications for the Characterization of Oligometastatic Disease.
    Kim J; Chang JS; Sung W; Kim JS; Kim TH; Choi SH; Kim KH; Ko H; Lee HS; Jeon S; Shin SJ; Liu M; Olson R
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):883-891. PubMed ID: 36007725
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment - A multicenter analysis.
    Frost N; Roeper J; Velthaus JL; Raspe M; Olive E; Schmittel A; Schmidt B; Wasilewski D; Onken J; Lüders H; Witzenrath M; Senger C; Böhmer D; Loges S; Griesinger F; Modest DP; Grohé C
    Lung Cancer; 2022 Aug; 170():165-175. PubMed ID: 35803041
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study.
    Kroese TE; Christ SM; van Rossum PSN; Burger MDL; Buijs GS; Mühlematter U; Andratschke N; Ruurda JP; Hüllner M; Gutschow CA; van Hillegersberg R; Guckenberger M
    Radiother Oncol; 2022 Aug; 173():269-276. PubMed ID: 35753555
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical value of PET/CT in identifying patients with oligometastatic/oligoprogressive disease among first-line tyrosine kinase inhibitor-treated advanced EGFR-mutant non-small cell lung cancer: Implications from survival comparisons.
    Xu D; Yu F; Guo T; Zhou Y; Zhang J; Li Y; Jiang S; Mao J; Yang X; Chu L; Chu X; Wang S; Ni J; Zhu Z
    Br J Radiol; 2022 Aug; 95(1136):20220035. PubMed ID: 35611637
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis.
    Kroese TE; van Laarhoven HWM; Nilsson M; Lordick F; Guckenberger M; Ruurda JP; D'Ugo D; Haustermans K; van Cutsem E; van Hillegersberg R; van Rossum PSN
    Eur J Cancer; 2022 May; 166():254-269. PubMed ID: 35339868
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document.
    Lievens Y; Guckenberger M; Gomez D; Hoyer M; Iyengar P; Kindts I; Méndez Romero A; Nevens D; Palma D; Park C; Ricardi U; Scorsetti M; Yu J; Woodward WA
    Radiother Oncol; 2020 Jul; 148():157-166. PubMed ID: 32388150
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. EORTC Lung cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
    Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;
    Eur J Cancer; 2019 Nov; 122():109-114. PubMed ID: 31671363
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients.
    Frost N; Tessmer A; Schmittel A; van Laak V; Raspe M; Ruwwe-Glösenkamp C; Brunn M; Senger C; Böhmer D; Ochsenreither S; Temmesfeld-Wollbrück B; Furth C; Schmidt B; Neudecker J; Rückert JC; Suttorp N; Witzenrath M; Grohé C
    Lung Cancer; 2018 Nov; 125():164-173. PubMed ID: 30429016
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Results of salvage stereotactic radiosurgery in 14 patients with grade III or IV gliomas].
    Noël G; Ben Ammar CN; Feuvret L; Valery CA; Cornu P; Boisserie G; Simon JM; Hasboun D; Tep B; Delattre JY; Sanson M; Baillet F; Mazeron JJ
    Rev Neurol (Paris); 2004 May; 160(5 Pt 1):539-45. PubMed ID: 15269671
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The relationship between caloric response, oculomotor dysfunction and size of cerebello-pontine angle tumours.
    Bergenius J; Magnusson M
    Acta Otolaryngol; 1988; 106(5-6):361-7. PubMed ID: 3264653
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.